Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
XORTX Therapeutics Inc. (XRTX) had Weighted-Average Shares Outstanding (Diluted) of 2.43M for the most recently reported fiscal quarter, ending 2024-03-31.
Income Statement Financials | |
-- |
|
$-3.02M |
|
-- |
|
-- |
|
$1.09M |
|
$-1.09M |
|
$-1.93M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-3.02M |
|
$-1.09M |
|
$-1.07M |
|
2.43M |
|
Weighted-Average Shares Outstanding (Diluted) |
2.43M |
$-1.24 |
|
$-1.24 |
|
Balance Sheet Financials | |
$4.66M |
|
$0.02M |
|
$1.39M |
|
$6.05M |
|
$0.34M |
|
-- |
|
$3.22M |
|
$3.56M |
|
$2.49M |
|
$2.33M |
|
$2.49M |
|
2.90M |
|
Cash Flow Statement Financials | |
$-1.30M |
|
$-0.00M |
|
$1.70M |
|
$3.45M |
|
$3.84M |
|
$0.39M |
|
$0.05M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
13.68 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-121.19% |
|
-129.84% |
|
-49.89% |
|
-121.19% |
|
$0.86 |
|
$-0.54 |
|
$-0.54 |